| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 11.563 | 25.740 | 25.097 | 34.521 | 37.822 | 35.287 | 44.306 | 64.880 | 75.261 |
| Total Income - EUR | - | 11.563 | 25.743 | 25.097 | 34.521 | 39.898 | 35.275 | 47.635 | 65.040 | 85.816 |
| Total Expenses - EUR | - | 5.611 | 12.897 | 14.340 | 20.628 | 24.900 | 26.319 | 28.103 | 33.353 | 42.331 |
| Gross Profit/Loss - EUR | - | 5.952 | 12.846 | 10.757 | 13.893 | 14.998 | 8.956 | 19.532 | 31.687 | 43.486 |
| Net Profit/Loss - EUR | - | 5.837 | 12.492 | 10.506 | 13.548 | 14.772 | 8.665 | 19.098 | 31.051 | 40.931 |
| Employees | - | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 2 |
Check the financial reports for the company - Medeor Sano Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 47 | 0 | 0 | 15.575 | 11.205 | 7.467 | 3.068 | 1.275 | 27.925 |
| Current Assets | - | 7.183 | 17.353 | 19.519 | 13.170 | 16.696 | 10.654 | 23.585 | 35.650 | 36.737 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 2.323 | 2.185 | 236 | 2.820 | 5.373 | 4.905 | 6.810 | 21.752 | 17.390 |
| Cash | - | 4.860 | 15.168 | 19.283 | 10.350 | 11.323 | 5.749 | 16.775 | 13.898 | 19.347 |
| Shareholders Funds | - | 5.881 | 15.544 | 17.858 | 14.029 | 14.373 | 8.766 | 19.198 | 31.150 | 41.030 |
| Social Capital | - | 45 | 90 | 88 | 86 | 85 | 83 | 83 | 83 | 82 |
| Debts | - | 1.349 | 1.809 | 1.661 | 14.716 | 13.528 | 9.356 | 7.456 | 5.775 | 20.773 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.858 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Medeor Sano Srl